ID

34995

Beschreibung

Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02253459

Link

https://clinicaltrials.gov/show/NCT02253459

Stichworte

Versionen (1)
  1. 07.02.19 07.02.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

7. Februar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT02253459

Englisch

Eligibility Breast Cancer NCT02253459

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. histologically and/or cytologically diagnosed patients with advanced, metastatic breast cancer,lacking standard therapy or being failed to or recurrent after standard therapy;
Beschreibung

Secondary malignant neoplasm of female breast Advanced | Standard therapy Lacking | Standard therapy failed | BREAST CANCER METASTATIC RECURRENT Post Standard therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0346993
UMLS CUI [1,2]
C0205179
UMLS CUI [2,1]
C2936643
UMLS CUI [2,2]
C0332268
UMLS CUI [3,1]
C2936643
UMLS CUI [3,2]
C0231175
UMLS CUI [4,1]
C0741681
UMLS CUI [4,2]
C0687676
UMLS CUI [4,3]
C2936643
2. patients who have previously treated with ≤4 chemotherapeutic regimes;
Beschreibung

Prior Chemotherapy Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1265611
3. patients who have previously treated with an anthracyclin antibiotics and a taxane;
Beschreibung

Anthracycline Antibiotic | taxane

Datentyp

boolean

Alias
UMLS CUI [1]
C0003234
UMLS CUI [2]
C0215136
4. age 18 -70 years old, ecog performance status of 0-2; life expectancy of 3 months or more;
Beschreibung

Age | ECOG performance status | Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C1520224
UMLS CUI [3]
C0023671
5. patients with at least 1 measurable target lesion determined by ct;
Beschreibung

Target Lesion Measurable Quantity CT

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2986546
UMLS CUI [1,2]
C1513040
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0040405
6. neuropathy ＜ctc2 degree （nci ctc4.03）within 4 weeks prior to enrollment;
Beschreibung

Neuropathy CTCAE Grades

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0442874
UMLS CUI [1,2]
C1516728
7. basically normal results from routine blood test within 1 week prior to enrollment;
Beschreibung

Blood test normal

Datentyp

boolean

Alias
UMLS CUI [1]
C0919709
8. basically normal liver and renal functions within 1 week prior to enrollment;
Beschreibung

Liver function | Renal function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
9. no abnormal function for major internal organs, no heart diseases.
Beschreibung

Normal function Organ Internal Major | Heart Diseases Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C4296962
UMLS CUI [1,2]
C0178784
UMLS CUI [1,3]
C0205102
UMLS CUI [1,4]
C0205164
UMLS CUI [2,1]
C0018799
UMLS CUI [2,2]
C0332197
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. received chemotherapy, radiotherapy, therapies with hormones or molecularly targeted drugs 4 weeks prior to enrollment, or received other chemotherapies while participating in this trial;
Beschreibung

Chemotherapy | Therapeutic radiology procedure | Hormone Therapy | Molecular Targeted Therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0279025
UMLS CUI [4]
C2699893
2. patients with documented hypersensitivity to cremophor el, or patients with previous taxane treatment related sae;
Beschreibung

Hypersensitivity Cremophor EL | Taxane Related Serious Adverse Event

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0056476
UMLS CUI [2,1]
C0215136
UMLS CUI [2,2]
C0439849
UMLS CUI [2,3]
C1519255
3. patients of pregnancy or breast feeding;
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
4. patients refractory to previous standard capecitabine treatment, or patients received effective standard capecitabine treatment with less than 6 months of capecitabine clearance period;
Beschreibung

Unresponsive to Capecitabine Standard therapy | Capecitabine Standard therapy Effective | Clearance of Capecitabine Duration

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0205269
UMLS CUI [1,2]
C0671970
UMLS CUI [1,3]
C2936643
UMLS CUI [2,1]
C0671970
UMLS CUI [2,2]
C2936643
UMLS CUI [2,3]
C1280519
UMLS CUI [3,1]
C1382187
UMLS CUI [3,2]
C0671970
UMLS CUI [3,3]
C0449238
5. patients with uncontrolled brain metastasis, bone metastasis, planned recent surgery or local radiotherapy, or other emergency patients;
Beschreibung

Metastatic malignant neoplasm to brain Uncontrolled | Secondary malignant neoplasm of bone | Operative Surgical Procedures Planned | Therapeutic radiology procedure Local Planned | Emergency Patients

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0153690
UMLS CUI [3,1]
C0543467
UMLS CUI [3,2]
C1301732
UMLS CUI [4,1]
C1522449
UMLS CUI [4,2]
C0205276
UMLS CUI [4,3]
C1301732
UMLS CUI [5,1]
C0013956
UMLS CUI [5,2]
C0030705
6. patients combined with severe and /or uncontrolled medical conditions, including severe cardiovascular disease, uncontrolled diabetes and high blood pressure, severe infection, severe gastrointestinal ulceration, and patients with incontrollable psychiatric history;
Beschreibung

Medical condition Severe | Medical condition Uncontrolled | Cardiovascular Disease Severe | Diabetic - poor control | Uncontrolled hypertension | Communicable Disease Severe | Gastrointestinal ulceration Severe | History of psychiatric disorder Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0205318
UMLS CUI [3,1]
C0007222
UMLS CUI [3,2]
C0205082
UMLS CUI [4]
C0421258
UMLS CUI [5]
C1868885
UMLS CUI [6,1]
C0009450
UMLS CUI [6,2]
C0205082
UMLS CUI [7,1]
C1963975
UMLS CUI [7,2]
C0205082
UMLS CUI [8,1]
C0455498
UMLS CUI [8,2]
C0205318
7. patients with poor compliance;
Beschreibung

Poor compliance

Datentyp

boolean

Alias
UMLS CUI [1]
C0032646
8. patients not fitted for this study determined by the investigators.
Beschreibung

Study Subject Participation Status Inappropriate

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1548788
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT02253459

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Secondary malignant neoplasm of female breast Advanced | Standard therapy Lacking | Standard therapy failed | BREAST CANCER METASTATIC RECURRENT Post Standard therapy
Item
1. histologically and/or cytologically diagnosed patients with advanced, metastatic breast cancer,lacking standard therapy or being failed to or recurrent after standard therapy;
boolean
C0346993 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C2936643 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
C2936643 (UMLS CUI [3,1])
C0231175 (UMLS CUI [3,2])
C0741681 (UMLS CUI [4,1])
C0687676 (UMLS CUI [4,2])
C2936643 (UMLS CUI [4,3])
Prior Chemotherapy Quantity
Item
2. patients who have previously treated with ≤4 chemotherapeutic regimes;
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Anthracycline Antibiotic | taxane
Item
3. patients who have previously treated with an anthracyclin antibiotics and a taxane;
boolean
C0003234 (UMLS CUI [1])
C0215136 (UMLS CUI [2])
Age | ECOG performance status | Life Expectancy
Item
4. age 18 -70 years old, ecog performance status of 0-2; life expectancy of 3 months or more;
boolean
C0001779 (UMLS CUI [1])
C1520224 (UMLS CUI [2])
C0023671 (UMLS CUI [3])
Target Lesion Measurable Quantity CT
Item
5. patients with at least 1 measurable target lesion determined by ct;
boolean
C2986546 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0040405 (UMLS CUI [1,4])
Neuropathy CTCAE Grades
Item
6. neuropathy ＜ctc2 degree （nci ctc4.03）within 4 weeks prior to enrollment;
boolean
C0442874 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Blood test normal
Item
7. basically normal results from routine blood test within 1 week prior to enrollment;
boolean
C0919709 (UMLS CUI [1])
Liver function | Renal function
Item
8. basically normal liver and renal functions within 1 week prior to enrollment;
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
Normal function Organ Internal Major | Heart Diseases Absent
Item
9. no abnormal function for major internal organs, no heart diseases.
boolean
C4296962 (UMLS CUI [1,1])
C0178784 (UMLS CUI [1,2])
C0205102 (UMLS CUI [1,3])
C0205164 (UMLS CUI [1,4])
C0018799 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Chemotherapy | Therapeutic radiology procedure | Hormone Therapy | Molecular Targeted Therapy
Item
1. received chemotherapy, radiotherapy, therapies with hormones or molecularly targeted drugs 4 weeks prior to enrollment, or received other chemotherapies while participating in this trial;
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0279025 (UMLS CUI [3])
C2699893 (UMLS CUI [4])
Hypersensitivity Cremophor EL | Taxane Related Serious Adverse Event
Item
2. patients with documented hypersensitivity to cremophor el, or patients with previous taxane treatment related sae;
boolean
C0020517 (UMLS CUI [1,1])
C0056476 (UMLS CUI [1,2])
C0215136 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
C1519255 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
3. patients of pregnancy or breast feeding;
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Unresponsive to Capecitabine Standard therapy | Capecitabine Standard therapy Effective | Clearance of Capecitabine Duration
Item
4. patients refractory to previous standard capecitabine treatment, or patients received effective standard capecitabine treatment with less than 6 months of capecitabine clearance period;
boolean
C0205269 (UMLS CUI [1,1])
C0671970 (UMLS CUI [1,2])
C2936643 (UMLS CUI [1,3])
C0671970 (UMLS CUI [2,1])
C2936643 (UMLS CUI [2,2])
C1280519 (UMLS CUI [2,3])
C1382187 (UMLS CUI [3,1])
C0671970 (UMLS CUI [3,2])
C0449238 (UMLS CUI [3,3])
Metastatic malignant neoplasm to brain Uncontrolled | Secondary malignant neoplasm of bone | Operative Surgical Procedures Planned | Therapeutic radiology procedure Local Planned | Emergency Patients
Item
5. patients with uncontrolled brain metastasis, bone metastasis, planned recent surgery or local radiotherapy, or other emergency patients;
boolean
C0220650 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0153690 (UMLS CUI [2])
C0543467 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
C1522449 (UMLS CUI [4,1])
C0205276 (UMLS CUI [4,2])
C1301732 (UMLS CUI [4,3])
C0013956 (UMLS CUI [5,1])
C0030705 (UMLS CUI [5,2])
Medical condition Severe | Medical condition Uncontrolled | Cardiovascular Disease Severe | Diabetic - poor control | Uncontrolled hypertension | Communicable Disease Severe | Gastrointestinal ulceration Severe | History of psychiatric disorder Uncontrolled
Item
6. patients combined with severe and /or uncontrolled medical conditions, including severe cardiovascular disease, uncontrolled diabetes and high blood pressure, severe infection, severe gastrointestinal ulceration, and patients with incontrollable psychiatric history;
boolean
C3843040 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0007222 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0421258 (UMLS CUI [4])
C1868885 (UMLS CUI [5])
C0009450 (UMLS CUI [6,1])
C0205082 (UMLS CUI [6,2])
C1963975 (UMLS CUI [7,1])
C0205082 (UMLS CUI [7,2])
C0455498 (UMLS CUI [8,1])
C0205318 (UMLS CUI [8,2])
Poor compliance
Item
7. patients with poor compliance;
boolean
C0032646 (UMLS CUI [1])
Study Subject Participation Status Inappropriate
Item
8. patients not fitted for this study determined by the investigators.
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video